Figure 1.
Myelosuppression monitoring rates by facility. Myelosuppression monitoring rates varied greatly based on facility with no correlation between the volume of inflammatory bowel disease patients on immunomodulators and monitoring rates.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.